120 related articles for article (PubMed ID: 20518030)
1. The outcome of cross-priming during virus infection is not directly linked to the ability of the antigen to be cross-presented.
Alatery A; Tarrab E; Lamarre A; Basta S
Eur J Immunol; 2010 Aug; 40(8):2190-9. PubMed ID: 20518030
[TBL] [Abstract][Full Text] [Related]
2. CTL induction by cross-priming is restricted to immunodominant epitopes.
Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
[TBL] [Abstract][Full Text] [Related]
3. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
4. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
7. Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD8+ T cells during subsequent viral infections.
Dunbar E; Alatery A; Basta S
Viral Immunol; 2007 Dec; 20(4):585-98. PubMed ID: 18158732
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
Walker CM; Paetkau V; Rawls WE; Rosenthal KL
J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
[TBL] [Abstract][Full Text] [Related]
9. No significant CTL cross-priming by dendritic cell-derived exosomes during murine lymphocytic choriomeningitis virus infection.
Coppieters K; Barral AM; Juedes A; Wolfe T; Rodrigo E; Théry C; Amigorena S; von Herrath MG
J Immunol; 2009 Feb; 182(4):2213-20. PubMed ID: 19201875
[TBL] [Abstract][Full Text] [Related]
10. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells.
Butz EA; Bevan MJ
J Immunol; 1998 Mar; 160(5):2139-44. PubMed ID: 9498751
[TBL] [Abstract][Full Text] [Related]
11. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
Bocharov GA
J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
[TBL] [Abstract][Full Text] [Related]
12. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
13. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
14. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
[TBL] [Abstract][Full Text] [Related]
15. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
16. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
[TBL] [Abstract][Full Text] [Related]
17. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
18. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
19. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
[TBL] [Abstract][Full Text] [Related]
20. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
Cole GA; Hogg TL; Coppola MA; Woodland DL
J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
